Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Landos Biopharma Inc.

    NASDAQ: LABP · Real-Time Price · USD
    22.93
    0.13 (0.57%)
    At close: May 23, 2024, 10:00 PM

    Landos Biopharma Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Cash & Equivalents
    		 29.05M 37.55M 42.41M 44.05M 45.24M 36.64M 28.88M 19.24M 11.29M 8.3M 17.89M 18.69M 8.57M
    Short-Term Investments
    		 n/a n/a 62K 687K 4.76M 7.76M 19.11M 36.51M 62.51M 82.58M 84.78M 96.44M 97.79M
    Long-Term Investments
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a n/a n/a n/a n/a n/a n/a 27K 26K n/a n/a n/a
    Receivables
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3K 2K 1K
    Inventory
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Current Assets
    		 842K 491K 710K 1.55M 1.18M 851K 1.5M 2.29M 3.56M 1.27M 1.65M 2.6M 3.39M
    Total Current Assets
    		 29.9M 38.04M 43.23M 46.28M 51.18M 45.25M 49.49M 58.04M 77.36M 92.15M 104.32M 117.73M 109.75M
    Property-Plant & Equipment
    		 n/a n/a n/a n/a n/a n/a n/a n/a 224K 707K 780K 564K 465K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Total Long-Term Assets
    		 n/a n/a n/a n/a n/a n/a n/a n/a 251K 733K 780K 564K 465K
    Total Assets
    		 29.9M 38.04M 43.23M 46.28M 51.18M 45.25M 49.49M 58.04M 77.61M 92.88M 105.1M 118.29M 110.21M
    Account Payables
    		 1.56M 1.38M 1.14M 1.03M 2.3M 3.44M 3.2M 4.71M 9.8M 12.91M 10.11M 10.69M 8.2M
    Deferred Revenue
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a n/a n/a n/a n/a n/a 27K n/a n/a n/a n/a
    Other Current Liabilities
    		 5.18M 4.87M 4.43M 1.99M 1.86M 2.69M 2.27M 1.8M 5.68M 3.7M 981K 1.84M 619K
    Total Current Liabilities
    		 6.74M 6.25M 5.57M 3.02M 4.16M 6.12M 5.47M 6.51M 15.51M 16.61M 11.1M 12.53M 8.82M
    Long-Term Debt
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 85K 149K 212K
    Total Long-Term Liabilities
    		 n/a n/a n/a n/a 2.3M 3.44M 3.2M 4.71M 9.83M 12.91M 85K 149K 212K
    Total Liabilities
    		 6.74M 6.25M 5.57M 3.02M 4.16M 6.12M 5.47M 6.51M 15.51M 16.61M 11.18M 12.68M 9.03M
    Total Debt
    		 n/a n/a n/a n/a n/a n/a n/a n/a 27K n/a n/a n/a n/a
    Common Stock
    		 31K 31K 31K 31K 312K 403K 403K 403K 403K 403K 401K 399K 399K
    Retained Earnings
    		 -164.26M -155.36M -149.24M -143.38M -139.46M -133.43M -128.19M -120.3M -109.02M -94.15M -74.05M -61.45M -65.55M
    Comprehensive Income
    		 n/a n/a -1K -7K 79K -57K -211K -392K -467K -225K 131K -142K -102K
    Shareholders Equity
    		 23.15M 31.79M 37.66M 43.27M 47.02M 39.13M 44.01M 51.53M 62.1M 76.27M 93.92M 105.61M 101.18M
    Total Investments
    		 n/a n/a 62K 687K 4.76M 7.76M 19.11M 36.51M 62.51M 82.58M 84.78M 96.44M 97.79M

    Add to Watchlist